1.A Clinical Study of Meales: in relation to measles vaccination.
Ra LEE ; Kyu Youp KIM ; Soo Jee MOON ; Chang Moo PARK
Journal of the Korean Pediatric Society 1981;24(3):191-197
No abstract available.
Meals*
;
Measles*
;
Vaccination*
2.A Case of Meningomyelocele Combined with Arnold-Chiari Malformation.
Kyu Youp KIM ; Hyeon Soo PARK ; Heung Jae LEE ; Keun Soo LEE
Journal of the Korean Pediatric Society 1981;24(12):1193-1196
No abstract available.
Arnold-Chiari Malformation*
;
Meningomyelocele*
3.A Case of Tuberculous Peritonitis Confirmed by Peritoneoscopy.
Jin CHOI ; Kyu Youp KIM ; Woo Gill LEE ; Choon Suk KEE ; Min AHN
Journal of the Korean Pediatric Society 1981;24(7):666-670
Tuberculous peritonitis is mainly transmitted via hematogenous spreading of tuberculous bacilli. But sometimes this disease is occured, as the abdominal lymph node infected by the localized tuberculous enteritis was ruptured We pressent the report and the brief review of related literatures, who experienced a case of tuberculous peritonitis confirmed by paracentiesis and peritoneoscopic examination in a 9 years old male patient who was suspected toa malignant tumor because of the recent unexplained abdominal distension.
Child
;
Enteritis
;
Humans
;
Laparoscopy*
;
Lymph Nodes
;
Male
;
Peritonitis, Tuberculous*
4.Result of a Mixture with Vegimil A(50%) and a known Local Infant Formular (50%) to Premature Infants.
Keun Soo LEE ; Soo Jee MOON ; Gwi Jong CHOI ; Sang Yoon LEE ; Kyu Youp KIM ; Kee Young YOUN ; Jin Woo HAHN
Journal of the Korean Pediatric Society 1983;26(1):1-7
No abstract available.
Humans
;
Infant*
;
Infant, Newborn
;
Infant, Premature*
5.Treatment of Callosal Arteriovenous Malformations.
Dong Youp LEE ; Seung Kon HUH ; Dong Ik KIM ; Yong Gou PARK ; Kyu Chang LEE
Journal of Korean Neurosurgical Society 2003;34(5):412-418
OBJECTIVE: To establish management strategy and to improve outcome of callosal arteriovenous malformations(AVMs), forty-six consecutive cases hospitalized from 1984 to 2001 are analyzed. METHODS: Clinical and radiologic files were reviewed. Average follow-up period was 20.3 months in microsurgery group, and 28.2 months in radiosurgery group. RESULTS: The resection rate of microsurgery was considered total in 12 patients(85.7% ), subtotal 2(14.3%). The final clinical outcome of microsurgery was good in 13 patients(92.8%), fair in 1(7.2%). One patient with splenial lesion had postoperative disconnection syndrome. Initial insults and hemodynamic complications were the major cause of an unfavorable outcome. In radiosurgery the complete regression of nidus was considered in 16 patients(51.6%), partial shrinkage in 13(41.9%), and no response in 2(6.5%). The clinical outcome of radiosurgery was good in 26 patients(83.9%), fair in 3(9.75%), and poor in 2(6.5%). Rebleeding during the latency period(3 patients), radiation necrosis(1 patients) and initial insults(1 patients) were the major cause of postradiosurgery morbidity. Rebleeding during the latency period occurred in 3 patients(9.7%). Two lesions were in the splenium, and one lesion in the body of corpus callosum. All lesions were larger than 3cm in diameter. Two of them occurred during the second year, and the rest one during the third year of latency period. CONCLUSION: Microsurgery, which eliminates the risk of bleeding immediately, is referred for callosal AVMs. Radiosurgery is another effective treatment modality for splenial lesions with large bridging veins that interfere with microsurgical approach, and combined endovascular treatment would be strongly recommended for the splenial lesions larger than 3cm in diameter that has higher risk of hemorrhage during the latency period.
Arteriovenous Malformations*
;
Corpus Callosum
;
Follow-Up Studies
;
Hemodynamics
;
Hemorrhage
;
Humans
;
Latency Period (Psychology)
;
Microsurgery
;
Radiosurgery
;
Veins
6.Duodenal Perforation due to Hemoclipping for the Dieulafoy's Lesion in a Duodenal Diverticulum.
Hyeuk PARK ; Kwang Hyun KO ; Jeong Ki KIM ; Hong Youp CHOI ; Sung Pyo HONG ; Sung Kyu HWANG ; Pil Won PARK ; Kyu Sung RIM
Korean Journal of Gastrointestinal Endoscopy 2005;30(3):160-163
Duodenal diverticulum usually originates in the second portion of the duodenum and occasionally causes duodenal obstruction, hemorrhage, perforation and diverticulitis. A bleeding from Dieulafoy's lesion in a duodenal diverticulum is rare. It is not easily dignosed and treated by forward viewing endoscopy. Recently, a case was reported describing the hemorrhage from the Dieulafoy's lesion in a duodenal diverticulum which was treated by hemoclip with forward viewing endoscopy. Hemoclip application is considered to be the most appropriate endoscopic treatment, because sclerotherapy, electrocoagulation or band ligation for Dieulafoy's lesion in the duodenal diverticulum may increase risk of duodenal perforation. We report a case of duodenal perforation due to hemoclip application for the treatment of Dieulafoy's lesion in a duodenal diverticulum.
Diverticulitis
;
Diverticulum*
;
Duodenal Obstruction
;
Duodenum
;
Electrocoagulation
;
Endoscopy
;
Hemorrhage
;
Ligation
;
Sclerotherapy
7.Elastase-Positive Neutrophils Are Associated With Refractoriness of Chronic Rhinosinusitis With Nasal Polyps in an Asian Population
Dong Kyu KIM ; Jin Youp KIM ; Young Eun HAN ; Joon Kon KIM ; Hee Suk LIM ; Kyoung Mi EUN ; Seung Koo YANG ; Dae Woo KIM
Allergy, Asthma & Immunology Research 2020;12(1):42-55
PURPOSE: Various immune cells, including eosinophils and neutrophils, are known to contribute to the development of chronic rhinosinusitis with nasal polyps (CRSwNP). However, the current understanding of the role of neutrophils in the development of CRSwNP still remains unclear. Therefore, we investigated risk factors for refractoriness of CRSwNP in an Asian population. METHODS: Protein levels of 17 neutrophil-related mediators in nasal polyps (NPs) were determined by multiplex immunoassay, and exploratory factor analysis using principal component analysis was performed. Immunofluorescence analysis was conducted to detect human neutrophil elastase (HNE) or myeloperoxidase (MPO)-positive cells. Tissue eosinophilic nasal polyp (ENP) and tissue neutrophilia (Neu(high)) were defined as greater than 70 eosinophils and 20 HNE-positive cells, otherwise was classified into non-eosinophilic nasal polyp (NENP) and absence of tissue neutrophilia (Neu(low)). RESULTS: In terms of disease control status, NENP-Neu(low) patients showed the higher rate of disease control than NENP-Neu(high) and ENP-Neu(high) patients. Linear by linear association demonstrated the trend in refractoriness from NENP-Neu(low) to NENP-Neu(high) or ENP-Neu(low) to ENP-Neu(high). When multiple logistic regression was performed, tissue neutrophilia (hazard ratio, 4.38; 95% confidence interval, 1.76-10.85) was found as the strongest risk factor for CRSwNP refractoriness. Additionally, exploratory factor analysis revealed that interleukin (IL)-18, interferon-γ, IL-1Ra, tumor necrosis factor-α, oncostatin M, and MPO were associated with good disease control status, whereas IL-36α and IL-1α were associated with refractory disease control status. In subgroup analysis, HNE-positive cells and IL-36α were significantly upregulated in the refractory group (P = 0.0132 and P = 0.0395, respectively), whereas MPO and IL-18 showed higher expression in the controlled group (P = 0.0002 and P = 0.0009, respectively). Moreover, immunofluorescence analysis revealed that IL-36R⁺HNE⁺-double positive cells were significantly increased in the refractory group compared to the control group. We also found that the ratio of HNE-positive cells to α1 anti-trypsin was increased in the refractory group. CONCLUSIONS: Tissue neutrophilia had an influence on treatment outcomes in the Asian CRSwNP patients. HNE-positive cells and IL-36α may be biomarkers for predicting refractoriness in Asians with CRSwNP. Additionally, imbalances in HNE and α1 anti-trypsin may be associated with pathophysiology of neutrophilic chronic rhinosinusitis.
Asian Continental Ancestry Group
;
Biomarkers
;
Eosinophils
;
Fluorescent Antibody Technique
;
Humans
;
Immunoassay
;
Interleukin 1 Receptor Antagonist Protein
;
Interleukin-18
;
Interleukins
;
Leukocyte Elastase
;
Logistic Models
;
Nasal Polyps
;
Necrosis
;
Neutrophils
;
Oncostatin M
;
Peroxidase
;
Principal Component Analysis
;
Rhinitis
;
Risk Factors
;
Sinusitis
8.The Effect of Repeated Education using a Computerized Scoring System for the Proper Use of Inhalation Medicine.
Sung Ken YU ; Sung Im PARK ; So Young PARK ; Jung Kyu PARK ; Sung Eun KIM ; Jung Youp KIM ; Kyeong Cheol SHIN ; Jin Hong CHUNG ; Kwan Ho LEE
Tuberculosis and Respiratory Diseases 2007;63(6):491-496
BACKGROUND: The best way of delivering drugs for the treatment of asthma and chronic obstructive pulmonary disease (COPD) is via the inhaled route of administration. However, many patients use inhaler devices incorrectly. To augment the proper use of inhalation medicine and to improve knowledge of the disease and compliance, we have developed a "Computerized Respiratory Service Program" and applied the use of this program to educate patients. METHODS: Prospectively, this study was performed in 164 patients with asthma or COPD prescribed with inhaled medication. When inhalation medication was first prescribed, education using a drug model was conducted two times and thereafter every month. In addition, education using a drug model was conducted and the ability of the patient to use inhalation medicine properly was evaluated. RESULTS: A total of 164 patients participated in the sessions more than two times and received education. Fifty-seven patients participated in three sesions. After the patients received education one time, the ability of these patients to use an inhaler had an average score of 20.6. After the patients received education two times, the average score was 21.9. After the patients received education three times, the average score was 22.3, a further increase. The compliance of using the inhaler was 70.1% at the second session and increased to 81.8% at the third session. CONCLUSION: Feedback education using the "Computerized Respiratory Service Program" will increase the ability of the patient to use an inhaler and consistent education can maintain patient compliance with inhaler use.
Asthma
;
Compliance
;
Education*
;
Humans
;
Inhalation*
;
Nebulizers and Vaporizers
;
Patient Compliance
;
Prospective Studies
;
Pulmonary Disease, Chronic Obstructive
9.Rhabdomyolysis Complicating Doxylamine Overdose.
So Young LEE ; Young Sun KANG ; Sang Youp HAN ; Jong Woo YOON ; Sang Kyung JO ; Dae Ryong CHA ; Won Yong CHO ; Hyoung Kyu KIM
Korean Journal of Nephrology 2001;20(1):120-126
BACKGROUND: Because of its ready availability in over-the-counter sleep preparations, doxylamine succinate is used frequently for suicidal attempts. Non-traumatic rhabdomyolysis is known to be a rare complication of doxylamine succinate but its pathogenesis and dose dependent effect are not known. The purpose of this study is to examine the frequency of various complications, especially rhabdomyolysis in doxylamine overdose and also to examine the effect of dose on the occurrence of these complications. METHODS: Medical records of patients who ingested doxylamine succinate from July 1996 to June 2000 were reviewed. Their age, sex, amount of ingestion and laborotory data are collected and also the occurrence of complication and dose-complication relationship were examined. RESULTS: 1) Total number of patients was 33 and average dose of ingestion was 1,510.6+/-180.7mg(150-5,000). 2) Complication rates were as follows tachycardia 20 patients(66%), hypertension 17 patients(51%), rhabdomyolysis 16 patients(48.4%), generalized seizure 7 patients(21.2%) and hyperthermia 5 patients(15.1%). 3) Tachycardia, seizure and rhabdomyolysis were occured more frequently in high dose groups. CONCLUSION: Rhbdomyolysis is not an infrequent complication in doxylamine overdose. Recognition of potential hazard for rhabdomyolysis and the institution of vigorous treatment to prevent acute renal failure, especially in patients who have taken a large amount of drugs will be required.
Acute Kidney Injury
;
Doxylamine*
;
Eating
;
Fever
;
Humans
;
Hypertension
;
Medical Records
;
Rhabdomyolysis*
;
Seizures
;
Succinic Acid
;
Tachycardia
10.Clinical Study of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Antagonist Combination Therapy in Renal Patients.
So Young LEE ; Young Sun KANG ; Sang Youp HAN ; Jong Woo YUN ; Sang Kyeng JO ; Dae Ryung CHA ; Won Yong CHO ; Hyoung Kyu KIM
Korean Journal of Nephrology 2000;19(6):1078-1085
BACKGROUND: Angiotensin-converting enzyme inhibitors(ACEi) do not decrease plasma angiotensin II levels in chronic use to the same extent as in acute use. this reincrease in angiotensin II level is explained either by a renin-mediated reactive rise in plasma angiotensin I or by non-ACE dependent angiotensin II generation. The aim of this study was to compare the additive effects of an ACEi and angiotensin II receptor antagonist(AT1a) in antiproteinuric effect, hyperkalemia, and hypotension. METHODS: 58 outpatients with chronic renal insufficiency were included and they were randomly classified into two groups : Group I(prescribed AT1a only), Group II(AT1a and ACEi combination therapy), and the changes of serum creatinine, the amount of proteinuria, the developement of hyperkalemia, and hypotension were evaluated. RESULTS: In group I, the amount of proteinuria decreased to 92.8% of initial amount at 1 month after the start of drugs. 2 of 28 patients(7.1%) developed hyperkalemia, and serum creatinine did not change (1.686+/-1.415mg/dL 1.821+/-1.301mg/dL, p=0.289). But in combination therapy group, serum creatinine level increased from baseline value of 1.466+/-0.619mg/dL to 1.800+/-0.881mg/dL(p=0.05), proteinuria did not change (101% of initial amount), and 7 of 30 patients(23.3%) developed hyperkalemia. CONCLUSION: Combination therapy seems to have no additive antiproteinuric effect, but serum creatinine and potassium levels should be closely monitered during the combination therapy.
Angiotensin I
;
Angiotensin II*
;
Angiotensins*
;
Creatinine
;
Humans
;
Hyperkalemia
;
Hypotension
;
Outpatients
;
Peptidyl-Dipeptidase A*
;
Plasma
;
Potassium
;
Proteinuria
;
Receptors, Angiotensin*
;
Renal Insufficiency, Chronic